Title
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Who is At Risk For Lupus? Key Demographics and Risk Factors

Why This Was Updated?

Our specialists regularly review advancements in health and wellness, ensuring our articles are updated with the newest information as it becomes accessible.
Medically Reviewed by

Lupus, specifically systemic lupus erythematosus (SLE), is a chronic autoimmune disease where the immune system mistakenly attacks healthy tissues, leading to inflammation in the skin, joints, kidneys, and other organs. 

Symptoms vary and may include fatigue, joint pain, skin rashes, and more severe complications like kidney inflammation, cardiovascular and lung problems, and neurological issues.

Recognizing the risk factors for lupus is critical for early detection, which can prevent severe complications and improve quality of life. Since lupus symptoms often mimic other conditions, understanding the demographics and triggers associated with the disease enables healthcare providers to identify at-risk individuals and provide timely care.

In this article, we’ll outline the key demographics and risk factors for lupus, focusing on prevention and early identification to reduce risk and improve patient outcomes.

[signup]

What Is Lupus? An Overview

Lupus is a complex autoimmune disease that occurs when the body’s immune system attacks its own tissues, causing widespread inflammation. There are four forms of lupus:

Systemic Lupus Erythematosus (SLE): the most common form of lupus, affecting multiple organs and systems.

Cutaneous Lupus: primarily affects the skin, often presenting as rashes or lesions. Cutaneous or skin lupus includes acute, subacute, or chronic (discoid) lupus erythematosus

Drug-Induced Lupus: a temporary lupus-like condition triggered by certain medications.

Neonatal Lupus: a rare form that affects newborns, often caused by antibodies passed from the mother.

Lupus can be difficult to diagnose due to its broad range of symptoms, which can include joint pain, skin rashes, fatigue, and fevers. Without proper treatment, lupus can lead to severe complications such as kidney failure, heart disease, and neurological disorders.

Prevalence of Lupus

Lupus affects about 5 million people worldwide, with approximately 1.5 million cases in the United States alone. It is most commonly diagnosed in women of childbearing age, although it can affect individuals of any age, gender, or ethnicity. 

Symptoms of Lupus

The diverse symptoms of lupus often make diagnosis challenging for clinicians. Common symptoms include:

  • Fatigue
  • Joint pain and swelling
  • Skin rashes, especially on sun-exposed areas
  • Fever
  • Photosensitivity
  • Oral ulcers
  • Kidney problems (lupus nephritis)
  • Neurological symptoms, such as seizures or memory loss
  • Eye problems 

Because lupus symptoms can overlap with other autoimmune conditions, identifying risk factors is necessary for an accurate and timely diagnosis.

Key Demographics at Risk for Lupus

Lupus overwhelmingly affects women of reproductive age, and tends to affect Black, Hispanic, Asian, and Native American populations more than Caucasians.

Gender as a Risk Factor

One of the most striking aspects of lupus is its disproportionate impact on women. 

Approximately 90% of lupus cases occur in females, especially during their reproductive years. This gender imbalance suggests that hormonal factors, particularly estrogen, play a key role in lupus development.

Estrogen modulates immune function, promoting B cell activity (a type of immune cell that makes antibodies) and autoantibody production, which can lead to autoimmunity. This is especially significant during childbearing years, when estrogen levels are high.

Hormonal changes, such as those during menstruation, pregnancy, or hormone replacement therapy (HRT), can trigger lupus flares. Many women experience flares during these times, while the risk decreases after menopause as estrogen declines. 

Hormonal therapies like oral contraceptives and HRT may also increase flare-ups and cardiovascular risks, particularly in women with antiphospholipid antibodies or thrombosis history.

It is important to consider lupus in premenopausal women with a wide symptom presentation, especially those with a family history and/or known genetic predisposition to SLE. 

Age of Onset

Lupus most commonly develops between the ages of 15 and 45, coinciding with women’s reproductive years. However, it can also occur outside this range.

Pediatric Lupus 

Lupus can present in children, though pediatric cases are less common. When it does occur, it tends to be more severe, with a higher likelihood of kidney involvement.

Late-Onset Lupus

In rare cases, lupus develops after age 50. These cases are often milder, but diagnosing lupus in older adults can be challenging due to overlapping symptoms with other age-related conditions.

Ethnicity and Lupus Risk

Lupus disproportionately affects individuals from certain ethnic backgrounds. African American, Hispanic, Asian, and Native American populations have higher rates of lupus compared to Caucasians.

These populations also tend to experience more severe lupus symptoms, including a higher risk of lupus nephritis.

Genetics play a role in making certain ethnic groups more susceptible to lupus. However, environmental factors such as exposure to sunlight or infections can also trigger disease onset in genetically predisposed individuals. 

Family History and Genetics

A family history of autoimmune diseases significantly increases the risk of developing lupus. 

A large Danish study found that having a relative with systemic lupus erythematosus (SLE) increases the likelihood of developing SLE or other autoimmune conditions. First-degree relatives, like siblings or children, are about 10 times more likely to develop SLE and are also at higher risk for autoimmune diseases like rheumatoid arthritis and type 1 diabetes. 

While second- and third-degree relatives also have an elevated risk, it's lower than that of close family members. 

Despite the increased risk, only about 2% of first-degree relatives are diagnosed with SLE over a 22-year period.

While no single gene causes lupus, researchers have identified several genes associated with increased lupus risk. These genes affect immune regulation and the body’s response to environmental triggers.

Environmental and Lifestyle Risk Factors

The environment has a profound effect on epigenetics, or gene expression. In lupus, this is important because certain genetic tendencies can make a person more likely to develop lupus, especially when exposed to certain environmental triggers.

Environmental Triggers

Environmental factors play a key role in triggering lupus flares and exacerbating symptoms in those who are genetically predisposed.

Ultraviolet (UV) Light

Exposure to sunlight is a well-known trigger for lupus flare-ups, particularly in those with photosensitivity. UV light can affect gene regulation and increase immune system activity, leading to inflammation and skin rashes.

Infections

Certain viral infections such as Epstein-Barr virus (EBV), Parvovirus B19, and HIV, are strongly linked to lupus development. These infections can overstimulate the immune system, potentially triggering lupus symptoms in susceptible individuals.

Pollution and Toxins

Exposure to environmental toxins like cigarette smoke, silica, and mercury may increase the risk of lupus by causing oxidative stress and immune dysfunction.

Lifestyle Choices

Lifestyle factors can also influence the development and progression of lupus.

Smoking and Alcohol

Smoking has been associated with an increased risk of developing lupus, as it contributes to immune system dysregulation and oxidative stress. One paper noted that smokers were three times more likely to develop SLE than nonsmokers.

Heavy alcohol consumption may exacerbate lupus symptoms, while light alcohol use has been shown to have a protective effect in some cases.

Stress and Lupus

Chronic stress is another potential trigger for lupus flares, as it can impair immune regulation and increase inflammation. Higher levels of stress have also been associated with poorer quality of life (QOL), higher disease activity, and worse health outcomes in lupus patients.

Managing stress through lifestyle modifications can help reduce the frequency and severity of lupus symptoms.

Other Health Conditions That Increase Lupus Risk

A history of autoimmunity, and regular use of certain medications, can increase the risk of developing lupus. 

Autoimmune Diseases

Individuals with other autoimmune diseases, such as rheumatoid arthritis, Sjögren’s syndrome, or Hashimoto’s thyroiditis, are at higher risk of developing lupus. This is known as Multiple Autoimmune Syndrome (MAS), where some patients are prone to developing more than one autoimmune condition.

Medications and Drug-Induced Lupus

Certain medications can induce lupus-like symptoms in some individuals. Common culprits include hydralazine (used to treat high blood pressure) and procainamide (used to treat heart arrhythmias). 

Both hydralazine and procainamide are DNA methylation inhibitors that provoke drug-induced lupus. Fortunately, drug-induced lupus typically resolves once the triggering medication is discontinued.

How to Mitigate Lupus Risk

A healthy lifestyle and avoidance of certain triggers may reduce a person’s risk of developing lupus or dealing with flares.

Managing Environmental Exposures

One of the most effective ways to reduce lupus risk is by managing exposure to known environmental triggers.

Sun Protection

Sunlight, especially UV radiation, is a well-known trigger for lupus flares. UV exposure reduces DNMT1 enzyme activity, which disrupts DNA methylation and activates certain genes, ultimately increasing disease activity. It also boosts the production of a protein called GADD45α, intensifying the immune response. 

Additionally, UV-induced oxidative stress generates reactive oxygen species (ROS), further lowering DNMT1 activity and causing immune cells to attack the body, leading to lupus flares.

Patients with lupus or those at risk should be advised to minimize UV exposure by wearing protective clothing, using sunscreen, and avoiding the sun during peak hours.

Healthy Lifestyle

Encouraging smoking cessation, reducing alcohol consumption, and promoting stress management can help lower the risk of lupus flares and improve overall health.

Practicing an anti-inflammatory lifestyle including following an anti-inflammatory diet may also reduce the risk of autoimmune flares.

Early Detection and Monitoring

For individuals at high risk of lupus, regular health checkups and monitoring are essential. This is especially true for patients with a family history of lupus or other autoimmune diseases.

Warning Signs

Early lupus symptoms, such as unexplained fatigue, joint pain, or skin rashes, especially in a person with other diagnosed autoimmune conditions; a family history of lupus; or a genetic predisposition to lupus, should be taken seriously. Prompt recognition and intervention can help prevent disease progression and organ damage.

[signup]

Key Takeaways

  • Lupus primarily affects women (90% of cases), especially during their reproductive years, and is more common in individuals of African American, Hispanic, Asian, and Native American descent. 
  • Key risk factors include hormonal changes, genetics, environmental triggers like UV light, and certain infections.
  • Individuals with lupus symptoms alongside other autoimmune diseases, a family history of lupus, or those exposed to triggers like sunlight and infections should consult healthcare professionals for early diagnosis and preventive care. Monitoring for symptoms like joint pain, fatigue, or skin rashes is crucial for timely intervention.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

No lab tests!

Bertagna, B. (2024, January 30). What Is The Best Diet For Lupus - Is There One?. Rupa Health. https://www.rupahealth.com/post/what-is-the-best-diet-for-lupus---is-there-one 

Cloyd, J. A Functional Medicine Approach to Addressing Hair Loss in Women. (2023, September 8). Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-addressing-hair-loss-in-women 

Cloyd, J. (2023, May 25). A Functional Medicine Hashimoto Treatment Protocol: Testing, Supplements, and Nutrition. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-hashimoto-treatment-protocol-testing-supplements-and-nutrition 

Conner, V. (2022, October 11). 6 Complementary and Alternative Therapies for Chronic Fatigue Syndrome. Rupa Health. https://www.rupahealth.com/post/6-natural-therapies-that-can-help-with-chronic-fatigue-symptoms 

Cox, A. D. (2022, August 10). Chronic Fatigue, Chest Pain, Stiffness, And Headaches Are All Signs Of This Autoimmune Disease. Rupa Health. https://www.rupahealth.com/post/natural-treatment-for-lupus

DeCesaris, L. 4 Genetic Tests That Can Help Individualize Treatment Options for Patients With Autoimmune Disease. (2023, June 7). Rupa Health. https://www.rupahealth.com/post/the-role-of-genetics-in-autoimmune-diseases 

Hasan, B., Fike, A., & Hasni, S. (2022). Health disparities in systemic lupus erythematosus-a narrative review. Clinical rheumatology, 41(11), 3299–3311. https://doi.org/10.1007/s10067-022-06268-y

Hedrich C. M. (2017). Epigenetics in SLE. Current rheumatology reports, 19(9), 58. https://doi.org/10.1007/s11926-017-0685-1

John Hopkins Medicine. (2023). Lupus Risk Factors. Www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/conditions-and-diseases/lupus/lupus-risk-factors

Jolly, M., & Katz, P. (2022). Predictors of stress in patients with Lupus. Frontiers in medicine, 9, 986968. https://doi.org/10.3389/fmed.2022.986968

Justiz Vaillant AA, Goyal A, Varacallo M. Systemic Lupus Erythematosus. [Updated 2023 Aug 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535405/

Khakham, C. (2023, July 21). Rupa Health. Integrative and Complementary Approach to Drug-Induced Lupus: Testing, Nutrition, and Supplements. https://www.rupahealth.com/post/integrative-and-complementary-approach-to-drug-induced-lupus-testing-nutrition-and-supplements 

Khakham, C. (2023, June 30). Integrative approaches to the treatment of lupus: A comprehensive review. Rupa Health. https://www.rupahealth.com/post/integrative-approaches-to-the-treatment-of-lupus-a-comprehensive-review 

Khakham, C. (2023, June 8). Exploring the Complexities of Autoimmune Diseases: Unraveling Mechanisms, Risk Factors, and Integrative Approaches to Testing, Diagnosis, and Treatment. Rupa Health. https://www.rupahealth.com/post/understanding-autoimmune-diseases-mechanisms-and-risk-factors

Khakham, C. (2023, May 3). How To Manage and Treat Autoimmune Disorders With Functional Testing and Nutrition. Rupa Health. https://www.rupahealth.com/post/how-to-manage-and-treat-autoimmune-disorders-with-functional-nutrition 

Khakham, C. (2023, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs 

Kim, J. W., Kim, H. A., Suh, C. H., & Jung, J. Y. (2022). Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus. Frontiers in medicine, 9, 906475. https://doi.org/10.3389/fmed.2022.906475

Kiyohara, C., Washio, M., Horiuchi, T., Asami, T., Ide, S., Atsumi, T., Kobashi, G., Tada, Y., Takahashi, H., & Kyushu Sapporo SLE (KYSS) Study Group (2012). Cigarette smoking, alcohol consumption, and risk of systemic lupus erythematosus: a case-control study in a Japanese population. The Journal of rheumatology, 39(7), 1363–1370. https://doi.org/10.3899/jrheum.111609

Kurup S, Pozun A. Biochemistry, Autoimmunity. [Updated 2022 Dec 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK576418/

Lalani, S., Pope, J., Leon, F. de, & Peschken, C. (2010). Clinical Features and Prognosis of Late-onset Systemic Lupus Erythematosus: Results from the 1000 Faces of Lupus Study. The Journal of Rheumatology, 37(1), 38–44. https://doi.org/10.3899/jrheum.080957

Lupus Foundation of America. (2021, July 23). Lupus facts and statistics. Lupus Foundation of America. https://www.lupus.org/resources/lupus-facts-and-statistics

Maholy, N. The Impact of Stress on Autoimmune Diseases: Exploring the Potential of Stress-Reduction Techniques. (2023, June 8). Rupa Health. https://www.rupahealth.com/post/the-impact-of-stress-on-autoimmune-diseases-and-the-potential-benefits-of-stress-reduction-techniques 

Mak, A., & Tay, S. H. (2014). Environmental factors, toxicants and systemic lupus erythematosus. International journal of molecular sciences, 15(9), 16043–16056. https://doi.org/10.3390/ijms150916043

Mazzucca, C. B., Raineri, D., Cappellano, G., & Chiocchetti, A. (2021). How to Tackle the Relationship between Autoimmune Diseases and Diet: Well Begun Is Half-Done. Nutrients, 13(11), 3956. https://doi.org/10.3390/nu13113956

McDaniel B, Sukumaran S, Koritala T, et al. Discoid Lupus Erythematosus. [Updated 2023 Aug 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493145/

Morey, J. N., Boggero, I. A., Scott, A. B., & Segerstrom, S. C. (2015). Current Directions in Stress and Human Immune Function. Current opinion in psychology, 5, 13–17. https://doi.org/10.1016/j.copsyc.2015.03.007

Oni, L., Wright, R. D., Marks, S., Beresford, M. W., & Tullus, K. (2021). Kidney outcomes for children with lupus nephritis. Pediatric nephrology (Berlin, Germany), 36(6), 1377–1385. https://doi.org/10.1007/s00467-020-04686-1

Pan, Q., Liu, Z., Liao, S., Ye, L., Lu, X., Chen, X., Li, Z., Li, X., Xu, Y.-Z., & Liu, H. (2019). Current mechanistic insights into the role of infection in systemic lupus erythematosus. Biomedicine & Pharmacotherapy, 117, 109122. https://doi.org/10.1016/j.biopha.2019.109122

Pediatric Systemic Lupus Erythematosus: Background, Etiology, Epidemiology. (2020). EMedicine. https://emedicine.medscape.com/article/1008066-overview

Pons-Estel, G. J., Alarcón, G. S., Scofield, L., Reinlib, L., & Cooper, G. S. (2010). Understanding the epidemiology and progression of systemic lupus erythematosus. Seminars in arthritis and rheumatism, 39(4), 257–268. https://doi.org/10.1016/j.semarthrit.2008.10.007

Richardson B. (2018). The interaction between environmental triggers and epigenetics in autoimmunity. Clinical immunology (Orlando, Fla.), 192, 1–5. https://doi.org/10.1016/j.clim.2018.04.005

Solhjoo M, Goyal A, Chauhan K. Drug-Induced Lupus Erythematosus. [Updated 2023 Apr 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441889/

Systemic Lupus Erythematosus (SLE) in Children. (n.d.). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/14796-systemic-lupus-erythematosus-sle-in-children

Ulff-Møller, C. J., Simonsen, J., Kyvik, K. O., Jacobsen, S., & Frisch, M. (2017). Family history of systemic lupus erythematosus and risk of autoimmune disease: Nationwide Cohort Study in Denmark 1977-2013. Rheumatology (Oxford, England), 56(6), 957–964. https://doi.org/10.1093/rheumatology/kex005

Vojdani, A. (2022, April 25). The Importance of Detecting Autoimmune Diseases During Preclinical and Clinical Stage. Rupa Health. https://www.rupahealth.com/post/the-importance-of-detecting-autoimmune-diseases-during-preclinical-and-clinical-stage

Wang, Z., Chang, C., Peng, M. et al. Translating epigenetics into clinic: focus on lupus. Clin Epigenet 9, 78 (2017). https://doi.org/10.1186/s13148-017-0378-7

Weckerle, C. E., & Niewold, T. B. (2011). The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clinical reviews in allergy & immunology, 40(1), 42–49. https://doi.org/10.1007/s12016-009-8192-4‌

Yoshimura, H. (2023, May 8). A Functional Medicine Systemic Lupus Erythematosus (SLE) Protocol: Testing, Diagnosing, and Treatment. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-systemic-lupus-erythematosus-sle-protocol-testing-diagnosing-and-treatment 

Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
See All Magazine Articles
Trusted Source
Rupa Health
Medical Education Platform
Visit Source
American Cancer Society
Foundation for Cancer Research
Visit Source
National Library of Medicine
Government Authority
Visit Source
Journal of The American College of Radiology
Peer Reviewed Journal
Visit Source
National Cancer Institute
Government Authority
Visit Source
World Health Organization (WHO)
Government Authority
Visit Source
The Journal of Pediatrics
Peer Reviewed Journal
Visit Source
CDC
Government Authority
Visit Source
Office of Dietary Supplements
Government Authority
Visit Source
National Heart Lung and Blood Institute
Government Authority
Visit Source
National Institutes of Health
Government Authority
Visit Source
Clinical Infectious Diseases
Peer Reviewed Journal
Visit Source
Brain
Peer Reviewed Journal
Visit Source
The Journal of Rheumatology
Peer Reviewed Journal
Visit Source
Journal of the National Cancer Institute (JNCI)
Peer Reviewed Journal
Visit Source
Journal of Cardiovascular Magnetic Resonance
Peer Reviewed Journal
Visit Source
Hepatology
Peer Reviewed Journal
Visit Source
The American Journal of Clinical Nutrition
Peer Reviewed Journal
Visit Source
The Journal of Bone and Joint Surgery
Peer Reviewed Journal
Visit Source
Kidney International
Peer Reviewed Journal
Visit Source
The Journal of Allergy and Clinical Immunology
Peer Reviewed Journal
Visit Source
Annals of Surgery
Peer Reviewed Journal
Visit Source
Chest
Peer Reviewed Journal
Visit Source
The Journal of Neurology, Neurosurgery & Psychiatry
Peer Reviewed Journal
Visit Source
Blood
Peer Reviewed Journal
Visit Source
Gastroenterology
Peer Reviewed Journal
Visit Source
The American Journal of Respiratory and Critical Care Medicine
Peer Reviewed Journal
Visit Source
The American Journal of Psychiatry
Peer Reviewed Journal
Visit Source
Diabetes Care
Peer Reviewed Journal
Visit Source
The Journal of the American College of Cardiology (JACC)
Peer Reviewed Journal
Visit Source
The Journal of Clinical Oncology (JCO)
Peer Reviewed Journal
Visit Source
Journal of Clinical Investigation (JCI)
Peer Reviewed Journal
Visit Source
Circulation
Peer Reviewed Journal
Visit Source
JAMA Internal Medicine
Peer Reviewed Journal
Visit Source
PLOS Medicine
Peer Reviewed Journal
Visit Source
Annals of Internal Medicine
Peer Reviewed Journal
Visit Source
Nature Medicine
Peer Reviewed Journal
Visit Source
The BMJ (British Medical Journal)
Peer Reviewed Journal
Visit Source
The Lancet
Peer Reviewed Journal
Visit Source
Journal of the American Medical Association (JAMA)
Peer Reviewed Journal
Visit Source
Pubmed
Comprehensive biomedical database
Visit Source
Harvard
Educational/Medical Institution
Visit Source
Cleveland Clinic
Educational/Medical Institution
Visit Source
Mayo Clinic
Educational/Medical Institution
Visit Source
The New England Journal of Medicine (NEJM)
Peer Reviewed Journal
Visit Source
Johns Hopkins
Educational/Medical Institution
Visit Source